Verve Therapeutics (VERV) Institutional Ownership $7.28 -0.55 (-7.02%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$7.44 +0.15 (+2.13%) As of 02/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Verve Therapeutics (NASDAQ:VERV)CurrentInstitutional OwnershipPercentage97.11%Number ofInstitutional Buyers(last 12 months)94TotalInstitutional Inflows(last 12 months)$105.85MNumber ofInstitutional Sellers(last 12 months)39TotalInstitutional Outflows(last 12 months)$71.69M Get VERV Insider Trade Alerts Want to know when executives and insiders are buying or selling Verve Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VERV Institutional Buying and Selling by Quarter Verve Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/19/2025 Public Employees Retirement System of Ohio106,356$600K0.0%+81.2%0.126% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC119,818$676K0.0%+4.2%0.142% 2/17/2025 Vestal Point Capital LP645,000$3.64M0.2%+22.9%0.762% 2/17/2025 Two Sigma Advisers LP293,200$1.65M0.0%+58.8%0.346% 2/17/2025 Two Sigma Investments LP570,304$3.22M0.0%+32.5%0.674% 2/17/2025 Tema Etfs LLC89,239$503K0.2%N/A0.105% 2/17/2025 Rafferty Asset Management LLC136,417$769K0.0%-35.3%0.161% 2/17/2025 Redmile Group LLC1,318,164$7.43M0.5%-4.7%1.557% 2/17/2025 Point72 Asset Management L.P.1,394,116$7.86M0.0%N/A1.647% 2/17/2025 ProShare Advisors LLC24,016$135K0.0%+30.4%0.028% Get the Latest News and Ratings for VERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Nuveen Asset Management LLC1,315,771$7.42M0.0%-21.3%1.554% 2/17/2025 Millennium Management LLC3,919,131$22.10M0.0%-22.0%4.629% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.144,749$816K0.0%+16.5%0.171% 2/17/2025 Jacobs Levy Equity Management Inc.1,848,071$10.42M0.0%+18.5%2.183% 2/17/2025 Graham Capital Management L.P.40,420$228K0.0%-44.0%0.048% 2/17/2025 Fiduciary Trust Co60,000$338K0.0%+20.0%0.071% 2/17/2025 D. E. Shaw & Co. Inc.37,984$214K0.0%N/A0.045% 2/17/2025 Deutsche Bank AG64,909$366K0.0%+55.7%0.077% 2/17/2025 Cubist Systematic Strategies LLC117,600$663K0.0%-82.7%0.139% 2/17/2025 BVF Inc. IL6,904,050$38.94M1.3%+962.2%8.155% 2/17/2025 Balyasny Asset Management L.P.85,116$480K0.0%+100.7%0.101% 2/17/2025 Bank of America Corp DE547,671$3.09M0.0%-29.4%0.647% 2/17/2025 BNP Paribas Financial Markets8,876$50K0.0%N/A0.010% 2/17/2025 Ameriprise Financial Inc.258,873$1.46M0.0%+14.5%0.306% 2/17/2025 Algert Global LLC188,005$1.06M0.0%-16.2%0.222% 2/17/2025 Acuta Capital Partners LLC160,200$904K0.9%+9.7%0.189% 2/14/2025 PDT Partners LLC53,291$301K0.0%-70.7%0.063% 2/14/2025 Schonfeld Strategic Advisors LLC3,789,379$21.37M0.1%+57.4%4.476% 2/14/2025 Northern Trust Corp650,562$3.67M0.0%+12.7%0.768% 2/14/2025 Boothbay Fund Management LLC53,317$301K0.0%+7.2%0.063% 2/14/2025 Susquehanna Fundamental Investments LLC291,383$1.64M0.0%N/A0.344% 2/14/2025 Virtus ETF Advisers LLC11,411$64K0.0%-30.7%0.013% 2/14/2025 Voya Investment Management LLC22,161$125K0.0%-6.5%0.026% 2/14/2025 Syon Capital LLC53,469$302K0.0%N/A0.063% 2/14/2025 T. Rowe Price Investment Management Inc.2,352,599$13.27M0.0%-3.0%2.779% 2/14/2025 Price T Rowe Associates Inc. MD28,998$164K0.0%-27.7%0.034% 2/14/2025 Dark Forest Capital Management LP21,416$121K0.0%-23.9%0.025% 2/14/2025 Stifel Financial Corp141,142$796K0.0%+7.4%0.167% 2/14/2025 Tower Research Capital LLC TRC 13,397$76K0.0%-49.0%0.016% 2/14/2025 Dimensional Fund Advisors LP437,089$2.47M0.0%+1.2%0.516% Has Trump finally met his match? (Ad)Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?Click here for his emergency broadcast...2/13/2025 Jump Financial LLC147,819$834K0.0%+26.2%0.175% 2/13/2025 Barclays PLC220,731$1.24M0.0%-1.0%0.261% 2/13/2025 Renaissance Technologies LLC363,400$2.05M0.0%-36.8%0.429% 2/13/2025 Legal & General Group Plc64,426$363K0.0%+15.4%0.076% 2/13/2025 Invesco Ltd.57,140$322K0.0%+5.7%0.067% 2/13/2025 Bank of Montreal Can44,139$249K0.0%-12.2%0.052% 2/13/2025 Russell Investments Group Ltd.76,038$429K0.0%-27.9%0.090% 2/13/2025 Wells Fargo & Company MN45,422$256K0.0%+25.0%0.054% 2/12/2025 Trexquant Investment LP635,847$3.59M0.0%+14.5%0.751% 2/12/2025 Geode Capital Management LLC1,625,780$9.17M0.0%+1.6%1.920% 2/12/2025 Alliancebernstein L.P.74,000$417K0.0%-11.3%0.087% 2/12/2025 Wellington Management Group LLP361,498$2.04M0.0%+4.2%0.427% 2/12/2025 Norges Bank78,186$441K0.0%N/A0.092% 2/12/2025 JPMorgan Chase & Co.417,539$2.36M0.0%-74.7%0.493% 2/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.50,230$313K0.0%+5.8%0.059% 2/11/2025 Corebridge Financial Inc.35,320$199K0.0%-7.0%0.042% 2/11/2025 Vanguard Group Inc.4,006,634$22.60M0.0%+0.0%4.733% 2/11/2025 LPL Financial LLC37,629$212K0.0%+94.5%0.044% 2/11/2025 KLP Kapitalforvaltning AS17,900$101K0.0%N/A0.021% 2/11/2025 American Century Companies Inc.127,464$719K0.0%+12.3%0.151% 2/11/2025 Teacher Retirement System of Texas20,254$114K0.0%+37.4%0.024% 2/10/2025 Commonwealth Equity Services LLC31,952$180K0.0%+17.6%0.038% 2/10/2025 Swiss National Bank133,100$751K0.0%+15.6%0.157% 2/7/2025 HighTower Advisors LLC20,428$115K0.0%N/A0.024% 2/6/2025 Arizona State Retirement System19,593$111K0.0%+15.8%0.023% 2/6/2025 Charles Schwab Investment Management Inc.570,718$3.22M0.0%-0.3%0.674% 2/5/2025 US Bancorp DE30,616$173K0.0%+62.8%0.036% 2/4/2025 Los Angeles Capital Management LLC231,123$1.30M0.0%-11.9%0.273% 2/4/2025 Bank of New York Mellon Corp220,502$1.24M0.0%+2.4%0.260% 2/4/2025 IFP Advisors Inc8,238$47K0.0%+823,700.0%0.010% 1/30/2025 Rhumbline Advisers111,203$627K0.0%+1.9%0.131% 1/24/2025 China Universal Asset Management Co. Ltd.17,952$101K0.0%+10.3%0.021% 1/21/2025 Impact Partnership Wealth LLC12,466$70K0.0%N/A0.015% 1/17/2025 Nisa Investment Advisors LLC42,781$241K0.0%+465.4%0.051% 1/13/2025 Green Alpha Advisors LLC29,438$166K0.1%+15.0%0.035% 1/10/2025 Harbor Capital Advisors Inc.41,544$234K0.0%-22.4%0.049% 1/3/2025 GAMMA Investing LLC6,054$34K0.0%+189.7%0.007% 12/26/2024 JPMorgan Chase & Co.1,647,844$7.98M0.0%-2.6%1.946% 11/27/2024 Franklin Resources Inc.34,155$172K0.0%+20.9%0.040% 11/19/2024 Barclays PLC222,919$1.08M0.0%+139.8%0.263% 11/16/2024 Geode Capital Management LLC1,600,687$7.75M0.0%+2.6%1.891% 11/15/2024 Barclays PLC222,919$1.08M0.0%+139.8%0.263% 11/15/2024 Public Employees Retirement System of Ohio58,700$284K0.0%+27.3%0.069% 11/15/2024 XTX Topco Ltd103,348$500K0.0%N/A0.122% 11/15/2024 Wellington Management Group LLP347,029$1.68M0.0%-6.5%0.410% 11/15/2024 State Street Corp4,253,217$20.59M0.0%+27.0%5.024% 11/15/2024 Stifel Financial Corp131,406$636K0.0%+14.7%0.155% 11/15/2024 Redmile Group LLC1,383,366$6.70M0.4%-5.5%1.634% 11/15/2024 Point72 DIFC Ltd17,143$83K0.0%N/A0.020% 11/15/2024 Ikarian Capital LLC170,000$823K0.1%N/A0.201% Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know.11/15/2024 Jacobs Levy Equity Management Inc.1,559,393$7.55M0.0%+72.2%1.842% 11/15/2024 Erste Asset Management GmbH11,300$56K0.0%N/A0.013% 11/14/2024 PFM Health Sciences LP125,999$610K0.0%N/A0.149% 11/14/2024 PDT Partners LLC181,803$880K0.1%-45.5%0.215% 11/14/2024 Braidwell LP623,980$3.02M0.1%N/A0.737% 11/14/2024 Verition Fund Management LLC28,714$139K0.0%N/A0.034% 11/14/2024 Vestal Point Capital LP525,000$2.54M0.2%+5.0%0.620% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC115,041$557K0.0%+6.1%0.136% 11/14/2024 Fiduciary Trust Co50,000$242K0.0%+400.0%0.059% 11/14/2024 Acuta Capital Partners LLC146,100$707K0.6%N/A0.173% (Data available from 1/1/2016 forward) VERV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VERV shares? During the previous two years, 139 institutional investors and hedge funds held shares of Verve Therapeutics. The most heavily invested institutionals were Casdin Capital LLC ($44.26M), BVF Inc. IL ($38.94M), Nikko Asset Management Americas Inc. ($34.35M), Vanguard Group Inc. ($22.60M), Millennium Management LLC ($22.10M), Schonfeld Strategic Advisors LLC ($21.37M), and State Street Corp ($20.59M).Learn more on VERV's institutional investors. What percentage of Verve Therapeutics stock is owned by institutional investors? 97.11% of Verve Therapeutics stock is owned by institutional investors. Learn more on VERV's institutional investor holdings. Which institutional investors have been buying Verve Therapeutics stock? Of the 117 institutional investors that purchased Verve Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($6.25M), ARK Investment Management LLC ($2.66M), Federated Hermes Inc. ($1.90M), Vanguard Group Inc. ($1.60M), Sumitomo Mitsui Trust Holdings Inc. ($1.40M), Point72 Asset Management L.P. ($1.39M), and Schonfeld Strategic Advisors LLC ($1.38M). How much institutional buying is happening at Verve Therapeutics? Institutional investors have bought a total of 26,879,934 shares in the last 24 months. This purchase volume represents approximately $242.41M in transactions. Which Verve Therapeutics major shareholders have been selling company stock? Of the 49 institutional investors that sold Verve Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ARK Investment Management LLC ($3.10M), Federated Hermes Inc. ($2.41M), Sumitomo Mitsui Trust Holdings Inc. ($1.52M), JPMorgan Chase & Co. ($1.34M), Millennium Management LLC ($1.11M), Wellington Management Group LLP ($843.16K), and Avidity Partners Management LP ($593.27K). How much institutional selling is happening at Verve Therapeutics? Institutional investors have sold a total of 14,603,829 shares in the last 24 months. This volume of shares sold represents approximately $102.25M in transactions. Related Companies MorphoSys Institutional Ownership Twist Bioscience Institutional Ownership Vericel Institutional Ownership Catalyst Pharmaceuticals Institutional Ownership MoonLake Immunotherapeutics Institutional Ownership Merus Institutional Ownership Beam Therapeutics Institutional Ownership ImmunityBio Institutional Ownership Arrowhead Pharmaceuticals Institutional Ownership HUTCHMED Institutional Ownership This page (NASDAQ:VERV) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recen...Brownstone Research | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verve Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
